Your browser doesn't support javascript.
loading
Adjuvant-free cellulose nanofiber vaccine induces permanent humoral immune response in mouse.
Ma, Ronglin; Xia, Wei; Zhang, Rui; Fan, Guojia; Sun, Libin; Qiu, Lei; Cui, Jinxin; Ju, Songwen; Wu, Pingping; Yang, Jie; Xiong, Jian; Yu, Qiang.
Afiliação
  • Ma R; Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215002, Jiangsu, People's Republic of China.
  • Xia W; Institute of Medical Biotechnology, Suzhou Vocational Health College, Suzhou 215009, Jiangsu, People's Republic of China.
  • Zhang R; Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu, People's Republic of China.
  • Fan G; Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu, People's Republic of China.
  • Sun L; Center for Cytotoxicity Testing, Sanitation & Environment Technology Institute, Soochow University, Suzhou 215006, Jiangsu, People's Republic of China.
  • Qiu L; Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215002, Jiangsu, People's Republic of China.
  • Cui J; Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215002, Jiangsu, People's Republic of China.
  • Ju S; Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215002, Jiangsu, People's Republic of China.
  • Wu P; Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou 215002, Jiangsu, People's Republic of China.
  • Yang J; Institute of Medical Biotechnology, Suzhou Vocational Health College, Suzhou 215009, Jiangsu, People's Republic of China.
  • Xiong J; Institute of Medical Biotechnology, Suzhou Vocational Health College, Suzhou 215009, Jiangsu, People's Republic of China.
  • Yu Q; Institute of Medical Biotechnology, Suzhou Vocational Health College, Suzhou 215009, Jiangsu, People's Republic of China.
Nanotechnology ; 33(34)2022 Jun 07.
Article em En | MEDLINE | ID: mdl-35580558
Vaccines have become one of the most effective strategies to deal with various infectious diseases and chronic noninfectious diseases, such as SARS virus, Novel Coronavirus, cancer, etc. However, recent studies have found that the neutralizing antibody titers induced by vaccines would drop to half level or even lower after vaccination. In this study, we designed a novel small-sized positively charged nanofiber-1 (PEI-CNF-1) as a vaccine carrier, which can induce a high long-term humoral immune response by controlled release of antigen. Further studies showed that PEI-CNF-1 could significantly induce the release of immune response factor IL-1ßand bone marrow-derived cell (BMDC) maturation. Moreover, compare to other cellulose nanofibers (CNFs), PEI-CNF-1 combined antigen (ovalbumin, OVA) induced and maintained the highest and longest antibody titers after vaccination. Interestingly, the antibody titers have no significant difference between at 21 and 90 d. Mechanically, we found that PEI-NCF-1 not only could control the slow-release of antigen, but also could be more easily swallowed by macrophages and metabolized by the bodies, thus presenting antigen more effectively. In conclusion, we believe that PEI-CNF-1 have a very high application prospect in inducing long-term humoral immune response, so as to achieve efficient prevention effect to epidemic viruses.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Nanofibras / COVID-19 Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Nanofibras / COVID-19 Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article